RYTM: Rhythm Pharmaceuticals Company Projected Revenue

Strategic alliances with research centers are accelerating patient recruitment for orphan drugs. The projected volume of sales activity demonstrates the commercial potential of Rhythm Pharmaceuticals (RYTM), where 0.28 serves as the final level marker. Professional management is successfully launching therapies into FDA and EMA markets, while sufficient capital mitigates the risks of insurance coverage delays for new Setmelanotide indications.

Company Projected Revenue: Rhythm Corp (RYTM) for 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company Rhythm Corp (RYTM)

- stock quotes and analyst forecast:

Stock Price Rhythm Pharmaceuticals, Inc.|RYTM - Price Target Chart

- market capitalization information:

Market Value Rhythm Pharma|RYTM - Total Enterprise Value

- balance sheet equity data:

Net Assets per Single Share Rhythm Pharmaceuticals|RYTM - Company Book Value|Market Capitalization to Book Value Ratio rhythmtx.com|RYTM - Company Total Asset Base

- debt level and financial liquidity data:

Debt to Equity Rhythm Pharmaceuticals|RYTM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity rhythmtx.com|RYTM - Company Total Debt|Debt to Book Capitalization Ratio Rhythm Pharmaceuticals|RYTM - Company Long-Term Loans and Borrowings|Company Short-Term Debts Rhythm Pharmaceuticals|Quick Liquidity Indicator rhythmtx.com

- company profitability and valuation multiples indicators:

RYTM - Company Net Income|Future Profit Rhythm Pharmaceuticals|RYTM - Market Price to Net Income Ratio|Forward P/E Multiple Rhythm Pharmaceuticals Inc|RYTM - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rhythm Pharmaceuticals|RYTM - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Rhythm Pharmaceuticals|RYTM - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months rhythmtx.com|RYTM - Earnings per share trend in current year|Earnings growth forecast for next year Rhythm Pharmaceuticals

- issuer revenue and sales details:

RYTM - Company Sales Revenue|Projected Sales Volume rhythmtx.com|RYTM - P/S Multiple|Price-to-Projected Revenue Ratio Rhythm Pharmaceuticals

Fundamental company analysis:RYTM Rhythm Pharmaceuticals, Inc.

Signature product of Rhythm Pharmaceuticals Inc

This indicator calculates the potential for generating future cash flows by assessing the business's ability to scale revenue through the lens of liquidity and market capitalization. For Rhythm Pharmaceuticals (RYTM), growth in this metric confirms the successful commercialization of drugs and a reduced reliance on external financing, which clearly reflects the company's planned sales volume in terms of dynamics.

Direct competitors